Skip to content
Inciteful Med

Planning Your Future: Genetics and Family Planning

Published: | Updated:

When planning a family with alpha-thalassemia, your baby's risk depends on whether your missing genes are on the same chromosome (cis) or different ones (trans). Screening your partner with a CBC, iron test, and DNA testing is the most critical step before conceiving.

Key Takeaways

  • • Alpha-thalassemia inheritance depends on the total number of missing alpha-globin genes from both parents.
  • • Having a 'cis' deletion carries a risk of passing on severe Hb Bart syndrome, while a 'trans' deletion does not.
  • • Partner screening should always begin with a complete blood count and iron test before proceeding to DNA testing.
  • • Carrying a pregnancy with Hb Bart syndrome poses life-threatening risks to the mother, including pre-eclampsia and Mirror Syndrome.
  • • Prenatal testing options like CVS, amniocentesis, and specialized ultrasounds can help monitor your baby's health before birth.

When you have alpha-thalassemia, planning for a family is about understanding the “dosage” of genes you might pass on. Because you have four alpha-globin genes (two on each of your two chromosome 16s), the way those genes are arranged determines the risk for your children [1][2].

The Inheritance Map

Alpha-thalassemia follows an autosomal recessive pattern, but with a twist: it depends on the total number of missing genes from both parents [1].

Why “Cis” vs. “Trans” Matters

If you have the two-gene deletion (Alpha-Thal Trait), your genes are arranged in one of two ways:

  • Trans (-α/-α): You have one missing gene on each chromosome. You can only pass on exactly one missing gene to a child. You have zero risk of having a child with Hb Bart syndrome (the most severe form). However, if your partner has a ‘cis’ deletion, there is still a risk of having a child with HbH disease [3][4].
  • Cis (–/αα): Both missing genes are on the same chromosome. You could pass on a chromosome with two missing genes. If your partner also passes on a chromosome with two missing genes, the child would have Hb Bart syndrome (4 missing genes) [3][5].

Screening Your Partner

Before conceiving, the most important step is for your partner to be screened. This process happens in layers:

  1. Step 1: The CBC. Your partner should have a Complete Blood Count. If their MCH and MCV (cell size and color) are normal, the risk is very low [6][7].
  2. Step 2: Iron Levels. If your partner’s CBC shows small red blood cells, they must first have their ferritin (iron) levels checked to rule out simple iron deficiency before jumping to expensive genetics [8].
  3. Step 3: DNA Testing. If iron levels are normal, standard electrophoresis often misses alpha-thalassemia, so molecular DNA testing is the only way to be sure [9][8].
  4. Step 4: Silent Carrier Check. Even if your partner’s CBC is normal, they could still be a silent carrier (missing 1 gene). If you have a “cis” deletion, it may be worth your partner having DNA testing anyway to rule out the risk of having a child with HbH disease [7][1].

Maternal Health Risks with Hb Bart’s

It is absolutely critical to know that carrying a pregnancy with Hb Bart syndrome is not just a risk to the fetus; it poses life-threatening risks to the pregnant mother. These risks include severe pre-eclampsia and Mirror Syndrome (where the mother’s body mimics the severe swelling and fluid buildup of the fetus). High-risk maternal-fetal monitoring is essential to protect the mother’s life [10][11].

Your Options During Pregnancy

If you and your partner are both carriers and are at high risk for a severe form of thalassemia, you have several choices to monitor the health of the pregnancy:

  • Chorionic Villus Sampling (CVS): Performed between 10 and 13 weeks of pregnancy. A small sample of the placenta is taken to test the baby’s DNA directly [12][1].
  • Amniocentesis: Performed after 15 weeks. A sample of the amniotic fluid is taken to test the baby’s DNA [12][13].
  • Specialized Ultrasound: Doctors can use ultrasound to measure the blood flow in the baby’s brain (MCA-PSV) or the size of the baby’s heart. These are non-invasive ways to check for signs of anemia before birth [14][15].
  • NIPT (Non-Invasive Prenatal Testing): This is a newer, emerging technology that tests the baby’s DNA using a simple blood draw from the mother. While highly promising, it is not yet as widely available for thalassemia as the invasive tests [16][17].

Knowledge is your most powerful tool. By understanding your specific genetic makeup, you can make informed decisions that are right for your family.

Frequently Asked Questions

What is the difference between cis and trans alpha-thalassemia?
In a trans trait, you have one missing gene on each chromosome, meaning you have zero risk of passing on the most severe form, Hb Bart syndrome. In a cis trait, both missing genes are on the same chromosome, which significantly increases the risk of severe thalassemia for your baby if your partner is also a carrier.
How should my partner be screened for alpha-thalassemia?
Your partner should first get a complete blood count (CBC) and an iron test to rule out basic iron deficiency. If their results are abnormal, or if you have a high-risk 'cis' trait, they will need molecular DNA testing to accurately check if they are a silent carrier.
Are there pregnancy risks for the mother if the baby has severe alpha-thalassemia?
Carrying a baby with Hb Bart syndrome poses life-threatening risks to the mother, including severe pre-eclampsia and Mirror Syndrome, where the mother's body mimics the baby's dangerous fluid buildup. High-risk maternal-fetal monitoring is essential to protect the mother's life.
What prenatal testing options are available for alpha-thalassemia?
Doctors can test the baby's DNA directly using Chorionic Villus Sampling (CVS) between 10-13 weeks or amniocentesis after 15 weeks. They can also use specialized non-invasive ultrasounds to check the baby's blood flow and heart size for signs of anemia.

Questions for Your Doctor

  • • Do I have a 'cis' or 'trans' deletion, and what does that mean for my children?
  • • If my partner's blood work is normal, is there still a risk they could be a silent carrier?
  • • Can you refer us to a genetic counselor to discuss our specific inheritance risks?
  • • What is the timeline for prenatal testing like CVS or amniocentesis if we decide to pursue them?
  • • Are non-invasive prenatal testing (NIPT) options available for alpha-thalassemia in this clinic?

Questions for You

  • • Have I shared my diagnosis with my partner so we can plan our screening together?
  • • Is there a history of 'anemia' or fetal loss in my or my partner's family that we should mention to the doctor?
  • • What are my personal priorities and values regarding prenatal testing and family planning?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Analysis of Deletional Hb H Diseases in Samples with Hb A2-Hb H and Hb A2-Hb Bart's on Capillary Electrophoresis.

    Khongthai K, Ruengdit C, Panyasai S, Pornprasert S

    Hemoglobin 2019; (43(4-5)):245-248 doi:10.1080/03630269.2019.1683573.

    PMID: 31687860
  2. 2

    [Clinical practice guidelines for alpha-thalassemia].

    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association , Shang X, Zhang X, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(3)):235-242 doi:10.3760/cma.j.issn.1003-9406.2020.03.003.

    PMID: 32128738
  3. 3

    Prenatal diagnosis and management of fetal discordant alpha-thalassaemia in dichorionic diamniotic (DCDA) twins.

    Panchalee T, Ruangvutilert P, Limsiri P, Sutcharitpongsa P

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-224362.

    PMID: 30366888
  4. 4

    Genotypes of thalassemia in children: an analysis of 30 417 cases.

    Li DM, He S

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2021; (23(8)):841-847 doi:10.7499/j.issn.1008-8830.2104035.

    PMID: 34511175
  5. 5

    A comprehensive preimplantation genetic testing approach for SEA-type α-thalassemia by fluorescent gap-polymerase chain reaction combined with haplotype analysis.

    Wang J, Ma Y, Guo J, et al.

    Frontiers in genetics 2023; (14()):1248358 doi:10.3389/fgene.2023.1248358.

    PMID: 38075678
  6. 6

    Molecular and Haematological Characteristics of alpha-Thalassemia Deletions in Yogyakarta Special Region, Indonesia.

    Husna N, Handayani NSN

    Reports of biochemistry & molecular biology 2021; (10(3)):346-353 doi:10.52547/rbmb.10.3.346.

    PMID: 34981010
  7. 7

    [Characteristics of Silent Alpha Thalassemia Gene in Child-Bearing Adults in Guangdong].

    Huang G, Zheng YW, Wu J, Liu SN

    Zhongguo shi yan xue ye xue za zhi 2023; (31(6)):1811-1814 doi:10.19746/j.cnki.issn.1009-2137.2023.06.032.

    PMID: 38071065
  8. 8

    Anemia among Medical Students from Jakarta: Indonesia-Iron Deficiency or Carrier Thalassemia?

    Wratsangka R, Tungka EX, Murthi AK, et al.

    Anemia 2024; (2024()):4215439 doi:10.1155/2024/4215439.

    PMID: 38716362
  9. 9

    Laboratory diagnosis of thalassemia.

    Brancaleoni V, Di Pierro E, Motta I, Cappellini MD

    International journal of laboratory hematology 2016; (38 Suppl 1()):32-40 doi:10.1111/ijlh.12527.

    PMID: 27183541
  10. 10

    Outcomes of pregnancies complicated by haemoglobin H-constant spring and deletional haemoglobin H disease: A retrospective cohort study.

    Ake-Sittipaisarn S, Sirichotiyakul S, Srisupundit K, et al.

    British journal of haematology 2022; (199(1)):122-129 doi:10.1111/bjh.18338.

    PMID: 35771858
  11. 11

    Investigation of the Influence of Deletional and Non-Deletional Hemoglobin H Disease on Pregnancy Outcomes.

    Zhao KS, Pan QA, Yang HY, et al.

    International journal of women's health 2025; (17()):1-7 doi:10.2147/IJWH.S497671.

    PMID: 39802921
  12. 12

    Invasive prenatal diagnosis of α-thalassemia to control Hb Bart's hydrops fetalis syndrome: 15 years of experience.

    Lai K, Li S, Lin W, et al.

    Archives of gynecology and obstetrics 2018; (298(2)):307-311 doi:10.1007/s00404-018-4807-4.

    PMID: 29948167
  13. 13

    Molecular characterization of Hb H disease in southern Thailand.

    Nittayaboon K, Nopparatana C

    International journal of hematology 2018; (108(4)):384-389 doi:10.1007/s12185-018-2494-3.

    PMID: 30006733
  14. 14

    The best cutoff value of middle cerebral artery peak systolic velocity for the diagnosis of fetal homozygous alpha thalassemia-1 disease.

    Tongprasert F, Srisupundit K, Luewan S, et al.

    Prenatal diagnosis 2019; (39(3)):232-237 doi:10.1002/pd.5419.

    PMID: 30650188
  15. 15

    Fetal heart size measurements as new predictors of homozygous α-thalassemia-1 in mid-pregnancy.

    Li X, Qiu X, Huang H, et al.

    Congenital heart disease 2018; (13(2)):282-287 doi:10.1111/chd.12568.

    PMID: 29368430
  16. 16

    A Pilot Study of Noninvasive Prenatal Diagnosis of Alpha- and Beta-Thalassemia with Target Capture Sequencing of Cell-Free Fetal DNA in Maternal Blood.

    Wang W, Yuan Y, Zheng H, et al.

    Genetic testing and molecular biomarkers 2017; (21(7)):433-439 doi:10.1089/gtmb.2016.0411.

    PMID: 28537755
  17. 17

    A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPT.

    Tsao DS, Silas S, Landry BP, et al.

    Scientific reports 2019; (9(1)):14382 doi:10.1038/s41598-019-50378-8.

    PMID: 31591409

This page provides educational information about alpha-thalassemia genetics and family planning. Always consult with a genetic counselor or maternal-fetal medicine specialist to discuss your specific inheritance risks.

Stay up to date

Get notified when new research about Alpha-thalassemia is published.

No spam. Unsubscribe anytime.